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Background
• 2nd year medical student
• Performed with Department of Radiation Oncology at St. Jude
Children’s Research Hospital
• Initial work performed in St. Jude 2021 POE program
• Follow-up worked performed throughout the fall semester
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Project Background
•

Proton therapy is used frequently in pediatric tumors
–
–
–

•

Adaptive therapy has been shown to benefit patients in
past research
–

•

More conformal dose distribution than photons
Beam can be shaped to avoid critical structures (organs-atrisk or OARs)
However: dose profile is more sensitive to variations

Depth-Dose Curves
Green: photon
Red: individual proton curves
Blue: "Spread out Bragg peak"

Adaptive therapy: adjusting treatment plan during treatment
to account for observed changes

Questions of interest
–
–
–

Can we describe tumor anatomic changes in our patient
population?
Can we quantify changes to dose distribution and determine
the impacts to treatment goals?
Does adaptive therapy benefit patients in this population?
Grant and Chang. 2014, Biomed Res Int.

Project Description
• 15 pediatric patients treated at St. Jude with upfront proton therapy
for parameningeal rhabdomyosarcoma (PM-RMS) on RMS13 trial
(NCT01871766)
• Retrospective analysis of benefits of adaptive therapy on this
population (who were treated with adaptive therapy methods
originally)
• Synthetic CT from MRI (using deformable image registration) allowed
generation of dose distribution changes during treatment
• “Updated” dose profiles allowed for analysis of effects of variations in
patient anatomy on tumor treatment parameters (dose to tumor and
OARs)

Uh et al. 2021, ASTRO Annual Meeting

Project Evaluation
• Most recent portion of the project focused on effects of dose
distribution variation on OARs
• Our theory was that some OARs would receive increased dose
because of changes in beam profile within patient
• We examined the dose profile changes to major OARs in head
and neck region during treatment
– Generated sCT scans -> updated dose distributions
– Delineation of key OARs on sequential MRI scans during treatment
– Determination of updated dose delivered on the updated patient
anatomy

Results and Conclusions
• 15 patients analyzed for dose changes to OARs
• Prior work had demonstrated 2/15 patients had significant decline
in tumor coverage (V95 < 95%)
• 7/15 had increase in dose to OARs (defined as increase of > 5%
initial prescribed dose to a key OAR)
• This reinforces the prior research work showing that adaptive
therapy can benefit proton therapy patients by preventing tumor
dose coverage failures and overdosing of OARs

Educational Aspects
• Gained knowledge on proton therapy and pediatric tumor
treatment
• Learned some of the language and medical underpinnings of
radiation therapy
• Learned how to use clinical radiation oncology software (Eclipse,
MIM)
• Brushed up on analysis capabilities in MATLAB

Most Challenging Aspect
• Several difficult areas, a few worth mentioning
• It was tough to delineate structure outlines with confidence (had
to review past images, prior structure outlines from clinicians, and
anatomy resources) esp. with pathology present
• Understanding the dosimetric outputs well enough to discern
“true” and “false” positive results
• Ensuring multi-step data processing (across different machines
and patients) was consistent, valid, and logical

Highlight of Project
• Looking back at the images in MIM (imaging software) and
seeing how much more data/analysis is there now than the
beginning
• Demonstrating merit in the initial research hypothesis
• Being able to continue my research experience from the summer
into the fall and now spring (and expand into different areas)
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